Document is current
Any future updates will be listed below
-
Authors
Quintero-Yanes, Alex https://orcid.org/0000-0002-8350-0881
Petit, Kenny
Rodriguez-Villalobos, Hector
Vande Capelle, Hanne https://orcid.org/0000-0003-3259-730X
De Veirman, Olivier
Gerstmans, Hans https://orcid.org/0000-0002-7469-5146
Masschelein, Joleen https://orcid.org/0000-0003-4366-3675
Borrero, Juan
Hols, Pascal https://orcid.org/0000-0001-8749-3650
Gabant, Philippe https://orcid.org/0009-0005-4378-9341
- License Information
-
More Information
Article History
Received: 15 January 2025
Accepted: 31 July 2025
First Online: 19 August 2025
Competing interests
: The authors declare the following competing interests: Juan Borrero (JB), Pascal Hols (PH) and Philippe Gabant (PG) declare that they are listed as inventors in the following patents and patent applications related to bacteriocin production and uses: J.B. and P.G., “Bacteriocin polypeptides, nucleic acids encoding same, and methods of use thereof”, Application PCT/US2023/067567; P.G., “Controlled growth of microorganisms”, US Patents 9,333,227/10,188,114/11,427,800/12,297,422 + CN ZL 201480057387.2/ZL 201910882176.7 + EP3035802B1 + BR112016003533-0/1220210154171 + IN389267; P.H.: “Peptides for inducing bacteriocin synthesis and methods to identify and/or select and/or optimize the same”, US Patent 12,234,299. P.H. is a member of the Scientific Advisory Board of the Syngulon company. All other authors declare no competing interests.
